Announcement on the Reply to the Inquiry Letter of the 2023 Annual Report by Hangzhou Tianmu Mountain Pharmaceutical Co., Ltd. to the Shanghai Stock Exchange.
2024 Third Extraordinary Shareholders' Meeting Materials of Hangzhou Tianmushan Pharmaceutical Co., Ltd.
Hangzhou Tianmu Mountain Pharmaceutical Co., Ltd. 2024 Second Extraordinary Shareholders' Meeting Materials.
Notice of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on convening the 3rd Extraordinary General Meeting of Shareholders in 2024
Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on the election of the board of directors and board of supervisors for a new term
Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on postponing the response to the Shanghai Stock Exchange's inquiry letter on the disclosure of information disclosure of the company's 2023 annual report
Notice of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on convening the 2nd Extraordinary General Meeting of Shareholders in 2024
Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on the implementation of production capacity improvement and technological transformation projects by its wholly-owned subsidiary Huangshan Tianmu Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Hangzhou Tianmushan Pharmaceutical Co., Ltd.
Legal Opinion of Shanghai Zechang Law Firm on the 2023 Annual General Meeting of Shareholders of Hangzhou Tianmusan Pharmaceutical Co., Ltd.
Hangzhou Tianmusan Pharmaceutical Co., Ltd. 2023 Annual General Meeting of Shareholders Meeting Materials
Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on plans not to distribute profits in 2023
Announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on applying to withdraw the company's stock delisting risk warning and continuing to implement other risk warnings
Report of the Audit Committee of the Board of Directors on the 2023 annual review of the performance of supervisory duties by accounting firms
Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on preparing for depreciation of various types of assets in 2023
Notice of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on holding the 2023 Annual General Meeting of Shareholders
Hangzhou Tianmushan Pharmaceutical Co., Ltd. 2023 Internal Control Evaluation Report
Report on the performance of the Audit Committee of the Board of Directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd. in 2023
Hangzhou Tianmushan Pharmaceutical Co., Ltd.'s 6th Risk Warning Notice Concerning the Possible Termination of the Company's Stock Listing
Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on the resignation of the deputy general manager and the appointment of senior management
No Data